Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Urinary Bladder Neoplasm|Triple Negative Breast Neoplasms|Carcinoma, Non-Small-Cell Lung|Ovarian Neoplasm
Interventions: DRUG: BT8009|DRUG: Pembrolizumab
Sponsor: BicycleTx Limited